Furegrelate

N/A

Report date: 2022/05/19 14:21:35
NME

Base Information

Drug NameFuregrelate
Drug Alias Name呋格雷酸U-63557A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitors
TargetsThromboxane A2 synthase
Therapy Area/IndicationsThrombosisMyocardial IschemiaArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial IschemiaArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksKEGG